Inventor · disambiguated record
Mark E. Adams
Also filed as: ADAMS MARK · ADAMS MARK E
7 granted patents·6 pending applications·108 citations·filing 1987–2023
82Inventor score
Files withTAKEDA PHARMACEUTICALS CO4LIGAND PHARM INC3HIGUCHI ROBERT I2TAKEDA PHARMACEUTICAL2BAXTER TRAVENOL LAB1
Top patents by PatentIndex Score
13 records- 0191US7214690B2Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methodsLIGAND PHARM INC·Filed 2002·Granted May 8, 2007·69 cites·58 claims
- 0271US7442696B2Mineralocorticoid receptor modulator compounds, processes for their preparation, and their usesLIGAND PHARM INC·Filed 2007·Granted Oct 28, 2008·1 cites·60 claims
- 0368US10000468B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 19, 2018·1 cites·10 claims
- 0463US2025340563A1Fused pyridazine derivatives as nlrp3 inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0556US4792449AMethod for drug administrationBAXTER TRAVENOL LAB·Filed 1987·Granted Dec 20, 1988·27 cites·11 claims
- 0651US10273225B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 30, 2019·0 cites·12 claims
- 0749US2008300241A9Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methodsHIGUCHI ROBERT I·Filed 2006·Application pending·0 cites
- 0849US2017327497A1Substituted 6-aza-isoindolin-1-one derivativesTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 0949US2008312307A1Mapk/erk kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2008·Application pending·0 cites
- 1048US7943659B2MAPK/ERK kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2007·Granted May 17, 2011·0 cites·30 claims
- 1147US6030643APotassium, sodium and tris oxaprozin salt pharmaceutical formulationsSEARLE & CO·Filed 1997·Granted Feb 29, 2000·10 cites·36 claims
- 1244US2007254917A1Intracellular receptor modulator compounds and methodsHIGUCHI ROBERT I·Filed 2007·Application pending·0 cites
- 1340US2009105292A9Glucocorticoid Receptor Modulator Compounds and MethodsLIGAND PHARM INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark E. Adams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →